Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo-epitope in horses.

Ekman S, Lindahl A, Rüetschi U, Jansson A, Björkman K, Abrahamsson-Aurell K, Björnsdóttir S, Löfgren M, Hultén LM, Skiöldebrand E.

Equine Vet J. 2019 Feb 10. doi: 10.1111/evj.13082. [Epub ahead of print]

PMID:
30739342
2.

Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.

Skiöldebrand E, Ekman S, Mattsson Hultén L, Svala E, Björkman K, Lindahl A, Lundqvist A, Önnerfjord P, Sihlbom C, Rüetschi U.

Equine Vet J. 2017 Sep;49(5):662-667. doi: 10.1111/evj.12666. Epub 2017 Feb 28.

3.

Characterisation of lubricin in synovial fluid from horses with osteoarthritis.

Svala E, Jin C, Rüetschi U, Ekman S, Lindahl A, Karlsson NG, Skiöldebrand E.

Equine Vet J. 2017 Jan;49(1):116-123. doi: 10.1111/evj.12521. Epub 2015 Dec 16.

PMID:
26507102
4.

SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients.

Rüetschi U, Stenson M, Hasselblom S, Nilsson-Ehle H, Hansson U, Fagman H, Andersson PO.

Int J Proteomics. 2015;2015:841769. doi: 10.1155/2015/841769. Epub 2015 Apr 28.

5.

An inflammatory equine model demonstrates dynamic changes of immune response and cartilage matrix molecule degradation in vitro.

Svala E, Löfgren M, Sihlbom C, Rüetschi U, Lindahl A, Ekman S, Skiöldebrand E.

Connect Tissue Res. 2015;56(4):315-25. doi: 10.3109/03008207.2015.1027340. Epub 2015 Apr 22.

PMID:
25803623
6.

SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Mehmedbasic A, Christensen SK, Nilsson J, Rüetschi U, Gustafsen C, Poulsen AS, Rasmussen RW, Fjorback AN, Larson G, Andersen OM.

J Biol Chem. 2015 Feb 6;290(6):3359-76. doi: 10.1074/jbc.M114.619940. Epub 2014 Dec 18.

7.

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

Hölttä M, Minthon L, Hansson O, Holmén-Larsson J, Pike I, Ward M, Kuhn K, Rüetschi U, Zetterberg H, Blennow K, Gobom J.

J Proteome Res. 2015 Feb 6;14(2):654-63. doi: 10.1021/pr501076j. Epub 2014 Dec 22.

PMID:
25490617
8.

Assignment of saccharide identities through analysis of oxonium ion fragmentation profiles in LC-MS/MS of glycopeptides.

Halim A, Westerlind U, Pett C, Schorlemer M, Rüetschi U, Brinkmalm G, Sihlbom C, Lengqvist J, Larson G, Nilsson J.

J Proteome Res. 2014 Dec 5;13(12):6024-32. doi: 10.1021/pr500898r. Epub 2014 Nov 17.

PMID:
25358049
9.

Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach.

Granéli C, Thorfve A, Ruetschi U, Brisby H, Thomsen P, Lindahl A, Karlsson C.

Stem Cell Res. 2014 Jan;12(1):153-65. doi: 10.1016/j.scr.2013.09.009. Epub 2013 Sep 27.

10.

Quantitative proteomics reveals regulatory differences in the chondrocyte secretome from human medial and lateral femoral condyles in osteoarthritic patients.

Stenberg J, Rüetschi U, Skiöldebrand E, Kärrholm J, Lindahl A.

Proteome Sci. 2013 Oct 4;11(1):43. doi: 10.1186/1477-5956-11-43.

11.

LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.

Halim A, Rüetschi U, Larson G, Nilsson J.

J Proteome Res. 2013 Feb 1;12(2):573-84. doi: 10.1021/pr300963h. Epub 2013 Jan 11.

PMID:
23234360
12.

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.

Portelius E, Olsson M, Brinkmalm G, Rüetschi U, Mattsson N, Andreasson U, Gobom J, Brinkmalm A, Hölttä M, Blennow K, Zetterberg H.

J Alzheimers Dis. 2013;33(1):85-93. doi: 10.3233/JAD-2012-120994.

PMID:
22886024
13.

O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner.

Gomez Toledo A, Raducu M, Cruces J, Nilsson J, Halim A, Larson G, Rüetschi U, Grahn A.

Glycobiology. 2012 Nov;22(11):1413-23. doi: 10.1093/glycob/cws109. Epub 2012 Jul 9.

PMID:
22781125
14.

An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.

Brinkmalm G, Portelius E, Öhrfelt A, Mattsson N, Persson R, Gustavsson MK, Vite CH, Gobom J, Månsson JE, Nilsson J, Halim A, Larson G, Rüetschi U, Zetterberg H, Blennow K, Brinkmalm A.

J Mass Spectrom. 2012 May;47(5):591-603. doi: 10.1002/jms.2987.

PMID:
22576872
15.

E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.

Boreström C, Forsman A, Rüetschi U, Rymo L.

J Gen Virol. 2012 May;93(Pt 5):1065-75. doi: 10.1099/vir.0.038752-0. Epub 2012 Feb 1.

PMID:
22302879
16.

Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD.

Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G.

Mol Cell Proteomics. 2012 Apr;11(4):M111.013649. doi: 10.1074/mcp.M111.013649. Epub 2011 Dec 14.

17.

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid.

Halim A, Brinkmalm G, Rüetschi U, Westman-Brinkmalm A, Portelius E, Zetterberg H, Blennow K, Larson G, Nilsson J.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11848-53. doi: 10.1073/pnas.1102664108. Epub 2011 Jun 28.

18.

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.

Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, Anckarsäter R, Anckarsäter H, Rosengren L, Holmberg B, Blennow K, Wikkelsö C, Rüetschi U, Zetterberg H.

Parkinsonism Relat Disord. 2010 Sep;16(8):545-9. doi: 10.1016/j.parkreldis.2010.06.011.

PMID:
20620095
19.

The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.

Johansson P, Jansson A, Rüetschi U, Rymo L.

J Virol. 2010 Mar;84(6):2787-97. doi: 10.1128/JVI.01052-09. Epub 2010 Jan 6.

20.

Enrichment of glycopeptides for glycan structure and attachment site identification.

Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.

Nat Methods. 2009 Nov;6(11):809-11. doi: 10.1038/nmeth.1392. Epub 2009 Oct 18.

PMID:
19838169
21.

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.

Westman-Brinkmalm A, Ruetschi U, Portelius E, Andreasson U, Brinkmalm G, Karlsson G, Hansson S, Zetterberg H, Blennow K.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1793-806. Review.

PMID:
19273163
22.

Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.

Johansson P, Jansson A, Rüetschi U, Rymo L.

J Virol. 2009 Feb;83(3):1393-401. doi: 10.1128/JVI.01637-08. Epub 2008 Nov 19.

23.

Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

Mattsson N, Rüetschi U, Pijnenburg YA, Blankenstein MA, Podust VN, Li S, Fagerberg I, Rosengren L, Blennow K, Zetterberg H.

Mol Med Rep. 2008 Sep-Oct;1(5):757-61. doi: 10.3892/mmr_00000025.

PMID:
21479482
24.

Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry.

Forsman A, Rüetschi U, Ekholm J, Rymo L.

J Proteome Res. 2008 Jun;7(6):2309-19. doi: 10.1021/pr700769e. Epub 2008 May 6.

PMID:
18457437
25.

Clinical proteomics in neurodegenerative disorders.

Zetterberg H, Rüetschi U, Portelius E, Brinkmalm G, Andreasson U, Blennow K, Brinkmalm A.

Acta Neurol Scand. 2008 Jul;118(1):1-11. doi: 10.1111/j.1600-0404.2007.00985.x. Epub 2008 Feb 13. Review.

PMID:
18279484
26.

Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis.

Mattsson N, Rüetschi U, Podust VN, Stridsberg M, Li S, Andersen O, Haghighi S, Blennow K, Zetterberg H.

J Neurochem. 2007 Dec;103(5):1932-9. Epub 2007 Oct 22.

27.

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.

Simonsen AH, Hansson SF, Ruetschi U, McGuire J, Podust VN, Davies HA, Mehta P, Waldemar G, Zetterberg H, Andreasen N, Wallin A, Blennow K.

Dement Geriatr Cogn Disord. 2007;23(4):246-50. Epub 2007 Feb 19.

PMID:
17310122
28.

Cystatin C in cerebrospinal fluid and multiple sclerosis.

Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andréasson U, Westman-Brinkmalm A, Wallin A, Rüetschi U, Blennow K.

Ann Neurol. 2007 Aug;62(2):193-6; discussion 205.

PMID:
16900522
29.

Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.

Rüetschi U, Rosén A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, Jacobsson B.

J Proteome Res. 2005 Nov-Dec;4(6):2236-42.

PMID:
16335971
30.

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

Rüetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K.

Exp Neurol. 2005 Dec;196(2):273-81. Epub 2005 Sep 8.

PMID:
16154129
31.

Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Dufva M, Flodin J, Nerstedt A, Rüetschi U, Rymo L.

Nucleic Acids Res. 2002 May 15;30(10):2131-43.

32.

Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.

Rüetschi U, Cerone R, Pérez-Cerda C, Schiaffino MC, Standing S, Ugarte M, Holme E.

Hum Genet. 2000 Jun;106(6):654-62.

PMID:
10942115
33.

Human 4-hydroxyphenylpyruvate dioxygenase gene (HPD).

Rüetschi U, Rymo L, Lindstedt S.

Genomics. 1997 Sep 15;44(3):292-9.

PMID:
9325050
34.

Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.

Lustig F, Hoebeke J, Ostergren-Lundèn G, Velge-Roussel F, Bondjers G, Olsson U, Rüetschi U, Fager G.

Biochemistry. 1996 Sep 17;35(37):12077-85.

PMID:
8810913
35.

Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line.

Baeckström D, Zhang K, Asker N, Rüetschi U, Ek M, Hansson GC.

J Biol Chem. 1995 Jun 9;270(23):13688-92.

36.

Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24-->qter by fluorescence in situ hybridization.

Stenman G, Röijer E, Rüetschi U, Dellsén A, Rymo L, Lindstedt S.

Cytogenet Cell Genet. 1995;71(4):374-6.

PMID:
8521727
37.

Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the gene.

Rüetschi U, Dellsén A, Sahlin P, Stenman G, Rymo L, Lindstedt S.

Eur J Biochem. 1993 May 1;213(3):1081-9.

38.

gamma-Butyrobetaine hydroxylase. Structural characterization of the Pseudomonas enzyme.

Rüetschi U, Nordin I, Odelhög B, Jörnvall H, Lindstedt S.

Eur J Biochem. 1993 May 1;213(3):1075-80.

39.

Characterization of 4-hydroxyphenylpyruvate dioxygenase. Primary structure of the Pseudomonas enzyme.

Rüetschi U, Odelhög B, Lindstedt S, Barros-Söderling J, Persson B, Jörnvall H.

Eur J Biochem. 1992 Apr 15;205(2):459-66.

Supplemental Content

Loading ...
Support Center